Trial · NCT00786474
Results by group18
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 18 of 18
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Arterial Thromboembolic Events | Placebo | Stroke | 2 | Arterial thromboembolic events | |
| Number of Arterial Thromboembolic Events | Dalteparin | Stroke | 3 | Arterial thromboembolic events | |
| Number of Arterial Thromboembolic Events | Placebo | Transient Ischemic Attack | 2 | Arterial thromboembolic events | |
| Number of Arterial Thromboembolic Events | Dalteparin | Transient Ischemic Attack | 0 | Arterial thromboembolic events | |
| Number of Arterial Thromboembolic Events | Placebo | Systemic embolism | 0 | Arterial thromboembolic events | |
| Number of Arterial Thromboembolic Events | Dalteparin | Systemic embolism | 0 | Arterial thromboembolic events | |
| Major Bleeding | Placebo | 12 | participants | ||
| Major Bleeding | Dalteparin | 29 | participants | ||
| Number of Subjects With Death, Acute Myocardial Infarction, Deep Vein Thrombosis, or Pulmonary Embolism | Placebo | Death | 5 | participants | |
| Number of Subjects With Death, Acute Myocardial Infarction, Deep Vein Thrombosis, or Pulmonary Embolism | Dalteparin | Death | 4 | participants | |
| Number of Subjects With Death, Acute Myocardial Infarction, Deep Vein Thrombosis, or Pulmonary Embolism | Placebo | Myocardial infarction | 7 | participants | |
| Number of Subjects With Death, Acute Myocardial Infarction, Deep Vein Thrombosis, or Pulmonary Embolism | Dalteparin | Myocardial infarction | 14 | participants | |
| Number of Subjects With Death, Acute Myocardial Infarction, Deep Vein Thrombosis, or Pulmonary Embolism | Placebo | Deep-vein thrombosis | 0 | participants | |
| Number of Subjects With Death, Acute Myocardial Infarction, Deep Vein Thrombosis, or Pulmonary Embolism | Dalteparin | Deep-vein thrombosis | 1 | participants | |
| Number of Subjects With Death, Acute Myocardial Infarction, Deep Vein Thrombosis, or Pulmonary Embolism | Placebo | pulmonary embolism | 0 | participants | |
| Number of Subjects With Death, Acute Myocardial Infarction, Deep Vein Thrombosis, or Pulmonary Embolism | Dalteparin | pulmonary embolism | 1 | participants | |
| Number of Participants With Minor Bleeding | Placebo | 110 | participants | ||
| Number of Participants With Minor Bleeding | Dalteparin | 187 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00786474/results